NCT06034288View on ClinicalTrials.gov

Xeomin vs Botox for Treatment of Overactive Bladder Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

September 30, 2024

Conditions
Overactive Bladder Syndrome
Interventions
DRUG

Xeomin 100 UNT Injection

intravesical injection

DRUG

Botox 100 UNT Injection

intravesical injection

Trial Locations (1)

20889

RECRUITING

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors
lead

Walter Reed National Military Medical Center

FED

NCT06034288 - Xeomin vs Botox for Treatment of Overactive Bladder Syndrome | Biotech Hunter | Biotech Hunter